Drug companies are paying patients to promote drugs on social media, and these “micro-influencers” are so influential they don’t need a big Facebook or Instagram following. Here & Now‘s Robin Young talks with Kate Sheridan (@sheridan_kate), reporter at STAT.
Copyright 2021 NPR. To see more, visit https://www.npr.org.